Anzeige
Mehr »
Freitag, 02.01.2026 - Börsentäglich über 12.000 News
Schon +250% im Plus - warum diese Goldstory gerade erst startet!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiApollo Global Management (APO) Explores Potential Sale of Aviation Company, Atlas Air Worldwide Holdings Inc., Reports Bloomberg
MiAccenture and Palantir Technologies (PLTR) Form Accenture Palantir Business Group
MiStrong Momentum Lifted BeOne Medicines AG (ONC) in Q3
MiAlibaba Group Holding (BABA) Limited Reported a Good Q3
MiNew Fortress (NFE) Falls 5% on Credit Concerns
MiHere's Why Genmab A/S (GMAB) Rose in Q3
MiASP Isotopes (ISP) Loses 5% as Exec Unloads Stake
MiHIVE Digital (HIVE) Drops 5% - Here's Why
MiRivian Automotive (RIVN) Loses 5% as CEO Unloads Stake
MiStrive Asset (ASST) Loses 5.3% on Lack of Devt
MiArray Technologies (ARRY) Drops 5.6% Ahead of Tax Credit Deadline
MiJPMorgan Has a Neutral Outlook on Zions Bancorporation (ZION)
MiBarclays Bullish on Western Alliance Bancorporation (WAL)
MiWells Fargo Has a Positive Outlook on Owens Corning (OC), Despite a Challenging Housing Market in 2026
MiHoldCo Urges Comerica (CMA) Shareholders to Vote No for Potential Merger with Fifth Third Bank
MiTrust Maintains a Hold Call on Citizens Financial Group (CFG), Noting Slight EPS Contraction in Banking Sector
MiTruist Maintains Hold Recommendation on KeyCorp (KEY)
MiMizuho Analyst Bullish on Fiserv (FISV) Amid Target Adjustments in Payments and IT Names
MiWells Fargo Sees Positive Drivers for American Airlines (AAL) Offset by Higher Debt
MiWhy These Energy Stocks are Losing This Week
Mi10 Stocks on Fire Ahead of 2026
MiBofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View
MiEli Lilly (LLY) Moves Fast to Secure Lead in India's Obesity Drug Market
MiJohnson & Johnson (JNJ) Ends Mid-Stage Eczema Study After Missing Efficacy Bar
MiBofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View